BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25842298)

  • 1. Chemopreventive effects of aspirin at a glance.
    Usman MW; Luo F; Cheng H; Zhao JJ; Liu P
    Biochim Biophys Acta; 2015 Apr; 1855(2):254-63. PubMed ID: 25842298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Colorectal Cancer Prevention by Aspirin-A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways.
    Sankaranarayanan R; Kumar DR; Altinoz MA; Bhat GJ
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
    Masmoudi A; Chevalier TL; Sabatier L; Soria JC
    Bull Cancer; 2004 May; 91 Suppl 2():S77-84. PubMed ID: 15899630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.
    Ornelas A; Zacharias-Millward N; Menter DG; Davis JS; Lichtenberger L; Hawke D; Hawk E; Vilar E; Bhattacharya P; Millward S
    Cancer Metastasis Rev; 2017 Jun; 36(2):289-303. PubMed ID: 28762014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin.
    Patrono C
    J Am Coll Cardiol; 2015 Jul; 66(1):74-85. PubMed ID: 26139061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1.
    Lichtenberger LM; Fang D; Bick RJ; Poindexter BJ; Phan T; Bergeron AL; Pradhan S; Dial EJ; Vijayan KV
    Cancer Prev Res (Phila); 2017 Feb; 10(2):142-152. PubMed ID: 27998883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
    Langley RE; Burdett S; Tierney JF; Cafferty F; Parmar MK; Venning G
    Br J Cancer; 2011 Oct; 105(8):1107-13. PubMed ID: 21847126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin as a chemopreventive agent for cutaneous melanoma: a literature review.
    Pulumati A; Algarin YA; Jaalouk D; Kim S; Latta S; Nouri K
    Arch Dermatol Res; 2024 Jun; 316(7):367. PubMed ID: 38850411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.
    Benamouzig R; Uzzan B; Martin A; Deyra J; Little J; Girard B; Chaussade S;
    Gut; 2010 May; 59(5):622-9. PubMed ID: 20427397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Annu Rev Public Health; 1997; 18():37-49. PubMed ID: 9143711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase inhibitors: From pharmacology to clinical read-outs.
    Patrignani P; Patrono C
    Biochim Biophys Acta; 2015 Apr; 1851(4):422-32. PubMed ID: 25263946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and safety of aspirin in the chemoprevention of colorectal cancer.
    Singh AK; Trotman BW
    J Assoc Acad Minor Phys; 1998; 9(2):40-4. PubMed ID: 9648425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
    Dachineni R; Kumar DR; Callegari E; Kesharwani SS; Sankaranarayanan R; Seefeldt T; Tummala H; Bhat GJ
    Int J Oncol; 2017 Dec; 51(6):1661-1673. PubMed ID: 29075787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398.
    Rioux N; Castonguay A
    Cancer Res; 1998 Dec; 58(23):5354-60. PubMed ID: 9850065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Platelets the Primary Target of Aspirin's Remarkable Anticancer Activity?
    Lichtenberger LM; Vijayan KV
    Cancer Res; 2019 Aug; 79(15):3820-3823. PubMed ID: 31300475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of aspirin in colorectal cancer chemoprevention.
    Singh Ranger G
    Crit Rev Oncol Hematol; 2016 Aug; 104():87-90. PubMed ID: 27289249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.